Title of article :
Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial
Author/Authors :
Hans-Christoph Diener، نويسنده , , Kai Kronfeld، نويسنده , , Gabriele Boewing، نويسنده , , Margitta Lungenhausen، نويسنده , , Christoph Maier، نويسنده , , Albrecht Molsberger، نويسنده , , Martin Tegenthoff، نويسنده , , Hans-Joachim Trampisch، نويسنده , , Michael Zenz، نويسنده , , Rolf Meinert and for the GERAC Migraine Study Group، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2006
Pages :
7
From page :
310
To page :
316
Abstract :
Summary Background Our aim was to assess the efficacy of a part-standardised verum acupuncture procedure, in accordance with the rules of traditional Chinese medicine, compared with that of part-standardised sham acupuncture and standard migraine prophylaxis with beta blockers, calcium-channel blockers, or antiepileptic drugs in the reduction of migraine days 26 weeks after the start of treatment. Methods This study was a prospective, randomised, multicentre, double-blind, parallel-group, controlled, clinical trial, undertaken between April 2002 and July 2005. Patients who had two to six migraine attacks per month were randomly assigned verum acupuncture (n=313), sham acupuncture (n=339), or standard therapy (n=308). Patients received ten sessions of acupuncture treatment in 6 weeks or continuous prophylaxis with drugs. Primary outcome was the difference in migraine days between 4 weeks before randomisation and weeks 23–26 after randomisation. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN52683557. Findings Of 1295 patients screened, 960 were randomly assigned to a treatment group. Immediately after randomisation, 125 patients (106 from the standard group) withdrew their consent to study participation. 794 patients were analysed in the intention-to-treat popoulation and 443 in the per-protocol population. The primary outcome showed a mean reduction of 2 •3 days (95% CI 1•9–2•7) in the verum acupuncture group, 1•5 days (1•1–2•0) in the sham acupuncture group, and 2•1 days (1•5–2•7) in the standard therapy group. These differences were statistically significant compared with baseline (p<0•0001), but not across the treatment groups (p=0•09). The proportion of responders, defined as patients with a reduction of migraine days by at least 50%, 26 weeks after randomisation, was 47% in the verum group, 39% in the sham acupuncture group, and 40% in the standard group (p=0•133). Interpretation Treatment outcomes for migraine do not differ between patients treated with sham acupuncture, verum acupuncture, or standard therapy.
Journal title :
Lancet Neurology
Serial Year :
2006
Journal title :
Lancet Neurology
Record number :
801651
Link To Document :
بازگشت